Browse by Year
/ 2009
/ January
/ Tuesday, January 06, 2009
[Federal Register: January 6, 2009 (Volume 74, Number 3)]
[Notices]
[Page 459-464]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06ja09-49]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 03-8]
Jayam Krishna-Iyer, M.D.; Suspension of Registration; Granting of
Renewal Application Subject to Condition
On September 1, 2006, I, the Deputy Administrator of the Drug
Enforcement Administration, ordered that the DEA Certificate of
Registration issued to Jayam Krishna-Iyer, M.D. (Respondent), of
Clearwater, Florida, be revoked. Jayam Krishna-Iyer, M.D., 71 FR 52148,
52159 (2006). The Order also denied Respondent's pending application
for renewal of her registration.
As grounds for the Order, I noted that Respondent had issued
prescriptions for controlled substances to three separate undercover
operatives notwithstanding that each of the operatives had indicated
that he was not in pain, and had told Respondent that he was obtaining
controlled substances from non-legitimate sources such as friends. Id.
at 52158. I further noted that Respondent had failed to conduct a
physical exam on each of the undercover operatives and had falsified
each operative's medical record to indicate that she had done an exam.
Id. I also noted that Respondent had made statements during each
operative's visit indicating that she knew that the operative was
seeking the drugs to abuse them and not to treat pain. Id. Finally, I
noted that Respondent had pre-signed prescriptions and given them to a
registered nurse in her employ, and that she allowed the nurse to issue
prescriptions to one of the operatives even though she did not attend
to the operative during the visit and the nurse lacked authority under
both Federal law and Florida law to prescribe controlled substances.
Id.
In the decision, I noted that Respondent had undertaken substantial
measures to reform her practice including hiring a private
investigation firm to review patient records to determine which
patients were likely substance abusers and should be discharged from
her practice; the firm also developed procedures for recognizing drug
abusers, doctor shoppers, prescription fraud, patients with a drug-
related criminal history, and dealing with claims of lost and stolen
medications. Id. at 52156. I also noted that the firm had conducted
extensive criminal history checks on Respondent's patients and that she
had discharged a large of number of patients. Id.
While I recognized the substantial measures that Respondent had
undertaken to reform her practice, I adopted the ALJ's finding that
Respondent failed to accept responsibility for her misconduct based on
her testimony that she did not intentionally or knowingly distribute a
controlled substance to the undercover operatives because she knew the
drugs would not be sold on the street. Id. at 52159. As I explained in
the Order, ``[i]t is no less a violation that the `patient' will
personally use the drug rather than sell it on the street.'' Id. I
further concluded that because Respondent had ``refuse[d] to
acknowledge her responsibilities under the law,'' the reforms she had
undertaken would ``still not adequately protect public health and
safety,'' and that this finding was dispositive as to whether her
continued registration would be consistent with the public interest.
Id.
Thereafter, Respondent filed a petition for review in the U.S.
Court of Appeals for the Eleventh Circuit. On September 25, 2007,
following briefing and oral argument, the Court vacated the Agency's
Order in an unpublished opinion. Krishna-Iyer v. DEA, No. 06-15034
(11th Cir. 2007), Slip Op. at 3. The Court declared:
In considering Petitioner's experience in dispensing controlled
substances under factor 2, the DEA identified only four visits by
three undercover `patient,' who were all attempting to make a case
against her. The DEA failed to consider Petitioner's experience with
twelve patients whose medical charts were seized by the DEA, or with
thousands of other patients. In short, the DEA did not consider any
of Petitioner's positive experience in dispensing controlled
substances. This is an arbitrary and unfair analysis of Petitioner's
experience.
Id. The Court therefore vacated the Order and remanded the case for
reconsideration, directing that ``DEA should pay particular attention
to the entire corpus of Petitioner's record in dispensing controlled
substances, not only the experience of [the] undercover officer.'' Id.
The Court further ordered that ``[t]he five factors should * * * be re-
balanced.'' Id.
On September 15, 2008, the Parties submitted a joint motion which
proposed a resolution of the matter. More specifically, the Parties
propose that I ``issue a new final Order consistent with the direction
of the * * * Court of Appeals.'' Joint Motion at 2. The Parties also
request that were I to find that ``revocation or suspension is still an
appropriate outcome,'' that the sanction be limited ``to suspension of
[her] registration for the time'' that the Final Order remained in
effect. The Parties also requested that I direct that Respondent's
pending renewal application be acted upon expeditiously. Finally, the
Parties represented that if I concurred with their proposed resolution,
they would enter into a Memorandum of Agreement (MOA) under which
Respondent's registration will be renewed subject to the condition that
for a one year period, she file monthly reports with the Agency's Miami
Field Division providing information regarding her prescribing of
controlled substances.
Attached to the Joint Motion was Respondent's statement. In her
[[Page 460]]
statement, Respondent: (1) ``Acknowledge[d] wrongdoing for failing to
conduct physical examinations of the three undercover patients in this
case''; (2) ``acknowledge[d] wrongdoing for improperly indicating on
the charts of the undercover patients that she had conducted a physical
examination of'' them; and (3) ``acknowledge[d] that she had presigned
various prescriptions and * * * understands that this was improper.''
Respondent's Statement at 1. Respondent also apologized for her conduct
with respect to each of the above actions and promises that she will
not engage in similar conduct in the future.\1\ Id.
Respondent also stated that she has reviewed the Agency's earlier
decision, that she ``has reexamined her conduct with respect to the
three undercover patients in light of the [Agency's] decision and has
re-evaluated the transcripts of the visits of the undercover patients
in light of the * * * decision.'' Id. Respondent further stated that
``she regret[ed] that she prescribed the medications which she
prescribed to the undercover patients'' and ``apologized * * * for her
conduct.'' Id. Respondent also promised that ``such conduct has not
occurred since [the undercover visits] and will not occur again.'' \2\
---------------------------------------------------------------------------
\1\ With respect to the pre-signing of prescriptions, Respondent
stated that ``she had not engaged in such conduct since being
advised by the DEA that such conduct was improper and promises that
she will not in the future.'' Respondent's Statement at 1.
\2\ Respondent also expressed regret and apologized for doctor-
shopping and inappropriate diversion of drugs at her clinic.
Respondent's Statement at 2. I acknowledge (as I did in the original
decision) the extensive efforts Respondent has undertaken to prevent
the diversion and abuse of drugs by her patients. I also acknowledge
Respondent's successful completion of the one-year period of
monitoring of her practice.
---------------------------------------------------------------------------
Findings
I incorporate by reference my findings of fact contained in the
original order and found at pages 71 FR at 52149-56. As previously
found, and as Respondent acknowledges, she issued controlled substance
prescriptions to three undercover operatives without performing
physical examinations on them and falsified medical records to indicate
that she had performed a physical exam. Moreover, Respondent prescribed
controlled substances to the undercover operatives even though each of
them represented that they were not in pain and were obtaining the
drugs from non-legitimate sources such as friends or family members.
Moreover, during each of the visits, Respondent made statements that
indicated that she knew the patients were seeking the drugs to abuse
them and not to treat a legitimate medical condition. See id. at 52150
(Respondent stating during first undercover visit: ``Lorcet 10/650.
See, this is a shame then that you have to take the medicine for the
habit.''); id. at 52152 (after acknowledging that second undercover
operative had told her that he was taking four to five Vicodin a day
even though he did not have pain, and was taking them because he
``functioned better,'' Respondent asked him if he ``want[ed] to go to
substance abuse program or * * * be maintained on the vicodin?''); id.
(stating to second undercover operative ``maybe I'm sympathetic to the
people that allow themselves to slip into drugs''); id. at 52154
(during visit of third operative, when asked by her nurse, ``what's the
source of the pain?,'' replying: ``I guess he feels no pain, he just
feels better.''); id. (stating to third visitor: ``we will not be
supporting just a drug habit'').
Having reviewed--for a second time--the twelve patient files that
were seized during the January 26, 2000 search, I further find that
Respondent discharged five of these patients prior to the search. More
specifically, I find that: (1) Respondent discharged K.L. on February
2, 1998, upon her office's being notified that she had altered a
prescription; (2) Respondent discharged R.H. on February 11, 1999, for
various reasons including his having claimed that his drugs had been
lost or stolen, and his coming in early to obtain new prescriptions
claiming that he was going out of town; (3) Respondent discharged J.B.
on December 1, 1998, after her office was notified that she had been
arrested for photocopying prescriptions and presenting them for filling
to multiple pharmacies; (4) Respondent discharged R.S. on December 2,
1999, after being called by his mother who reported that he was abusing
his medications; and (5) Respondent discharged J.L. on January 24,
2000, after an anonymous caller reported to Respondent's office that he
was simultaneously receiving treatment at a methadone clinic. See RX
21, at 4, 17, 23, 24 & 34
As stated above, the Court of Appeals vacated the original Order on
the ground that it failed to consider ``any of'' what it termed
[Respondent's] ``positive experience in dispensing controlled
substances.'' Slip. Op. at 3. The Court specifically noted that I had
not considered Respondent's experience with the twelve patients whose
charts were seized in a search of her office, ``or with thousands of
other patients.'' Id. at 3.
The Court of Appeals did not cite to any decision of either this
Agency or another court defining the term ``positive experience.'' Nor
did the Court offer any guidance as to the meaning of this term, which
is not to be found in the Act.
For the purpose of resolving this matter, I therefore assume--
without deciding--that the twelve patient charts establish that
Respondent's prescribing of controlled substance to these individuals
constitutes ``positive experience''--whatever that means.\3\
[[Page 461]]
Moreover, although there is absolutely no evidence in the record
regarding the propriety of Respondent's prescribing of controlled
substances to the ``thousands of other patients'' she has treated, for
the purpose of resolving this matter, I again assume that her
prescribings to these individuals constitutes ``positive experience.''
---------------------------------------------------------------------------
\3\ Having carefully re-reviewed the charts, it should be noted
that some of the files suggest that this is an assumption which is
highly favorable to Respondent. Under agency precedent, DEA's
authority to suspend or revoke a registration is not limited to
those instances in which a practitioner intentionally diverts. See
Paul J. Caragine, Jr., 63 FR 51592 (1998). A practitioner who
ignores the warning signs that her patients are either personally
abusing or diverting controlled substances commits ``acts
inconsistent with the public interest,'' 21 U.S.C. 824(a)(4), even
if she is merely gullible or na[iuml]ve. 63 FR at 51600. The twelve
patient charts cited by Respondent as evidence of her ``positive
experience'' included numerous instances in which Respondent appears
to have ignored warning signs that the patient was either abusing or
diverting controlled substances.
For example, according to Respondent's evidence, ``[o]n 10/05/99
a notation written in [C.A.'s] progress notes states, `That the
patient called to say that a [D.M.] will call and tell you I'm
selling my drugs.' It was later discovered that the patient was in
jail for violation of probation and marijuana.'' RX 21, at 2. In her
testimony, Respondent did not address what action she took in
response to this unusual phone call. See Tr. 433-34. Moreover, the
actual progress note for C.A.'s October 5 visit is missing. Also
missing are the progress notes for numerous other office visits
which occurred (according to Respondent's billing records) on
October 7 and 25, November 8 and December 17.
On July 28, 1998, Respondent issued a prescription for a drug
(Soma) to C.C. RX 21, at 8. That same day, Respondent's office
received a phone call from a Walgreens pharmacy reporting that two
days earlier, C.C. had filled a prescription for the same drug which
was issued by a different physician. Id. C.C. was thus clearly
engaged in doctor shopping.
Respondent saw C.C. three days later and yet there is no
indication in the progress note that she even questioned him about
the incident and whether he was seeing other doctors. RX 90, at 29.
At this visit, Respondent issued him a prescription for Dilaudid, a
schedule II controlled substance. Id. C.C. also demonstrated a
consistent pattern of coming in early. Respondent nonetheless
continued to prescribe controlled substances to him and did not
discharge him until approximately a year and a half after the
Walgreen's incident. RX 90, at 1.
Respondent had previously discharged R.H. based on a drug test
which showed that he was ``positive for drug dependency.'' RX 92, at
22. Respondent, however, accepted him back into her practice. Id. It
is acknowledged that upon his return to her practice, Respondent
counseled R.H. that if he returned ``to the same state of
medications taking'' as ``in the past, we will not be not be able to
continue.'' Id. During the visit, Respondent issued him a
prescription for Dilaudid. Id.
Two days later, however, R.H. returned to Respondent and
complained that he could only get part of his prescription filled
and that he had come back to get the balance of forty tablets.
Respondent ``continued his prescription for Dilaudid,'' id. at 21,
even though the original prescription was still valid under Federal
law.
After a number of additional visits, in early October, R.H. came
in and represented that his drugs had been ruined because he lived
in a duplex and the landlord's hot water heater had failed and
flooded the whole house. Id. at 16. As Respondent noted, R.H. had
brought in ``the whole bottle of Dilaudid with water in it. I cannot
tell if it is just a powder or medicine.'' Id. Respondent issued
R.H. a new prescription notwithstanding the likely implausibility of
his story and his past record as a drug abuser. Id. Nor is there any
evidence that she attempted to verify whether the substance in the
bottle was in fact Dilaudid. In addition, R.H. made numerous early
visits, and on another occasion, obtained prescriptions for
Oxycontin and Percocet after having claimed that he lost a
prescription for Dilaudid. Id. at 9.
While Respondent discharged J.B. on December 1, 1998, and
represents that J.B. was discharged after being arrested for
photocopying prescriptions, see RX 21, at 4; the online records of
the Pinellas County, Florida courts indicate that she had been
convicted on July 10, 1996, of attempting to obtain a controlled
substance by fraud, and that on June 9, 1998, a new complaint
charging her with obtaining or attempting to obtain a controlled
substance by fraud had been filed against her. Moreover, J.B. made
numerous early visits, a classic behavior of drug seekers. See RX
93.
R.C. came in on October 21, 1998, nine days after his initial
visit with Respondent, and told her that he had to come in early
because he was going to New York for four weeks and would run out of
medicine while he was out of town. RX 94, at 12. Yet eight days
later, R.C. was back to see Respondent and seeking additional
narcotics because he was ``going to Puerto Rico for some relief
work.'' Id. at 11. However, during R.C.'s initial visit, R.C. had
stated that he was ``on disability'' and was ``not working.'' Id. at
13. Respondent nonetheless issued him new prescriptions. Id. at 11.
While it is unclear whether R.C. told Respondent that he would be
gone for six weeks or six months, R.C. went back to see Respondent
on November 18 and 24, as well as on December 1, 1998. Id. at 15.
On August 21, 1998, Respondent gave B.B. a prescription for
Dilaudid (and Soma) for pain in various body parts and indicated
that she would be seen ``next month for the followup.'' RX 99, at 7.
On September 2 (eleven days later), B.B. returned to Respondent and
reported that ``she is going to Miami for about three to four weeks
for her deposition.'' Id. at 6. Respondent ``continued[d] her
prescriptions for Dilaudid and Soma.'' Id. Twelve days later, B.B.
returned to Respondent. Id. at 5. According to the progress note:
B.B. ``is going to Miami for her case. She will be gone four to six
weeks. She came in early today because she does not have enough
medicine for four to six weeks. `` Id. Respondent issued B.B.
additional prescriptions for Dilaudid (and Soma) and indicated that
she would be seen again in a month. Id. Ten days later, B.B.
returned again to Respondent. Id. at 4. According to the progress
note, B.B. ``came early today because she will be evacuated from the
Fort Lauderdale area. No more court cases.'' Id. B.B. also told
Respondent that the pharmacy had called and told her that ``they
could not fill the prescription, because it was unreadable,'' (as if
the pharmacy would not have called Respondent to verify the script)
and that B.B. ``could not get the prescription back from the
pharmacy, so she does not have any medicine [because] she had to
leave it in Fort Lauderdale.'' Id.
---------------------------------------------------------------------------
Discussion
Section 304(a) of the Controlled Substances Act (CSA) provides that
a registration to ``dispense a controlled substance* * * may be
suspended or revoked by the Attorney General upon a finding that the
registrant* * * has committed such acts as would render his
registration under section 823 of this title inconsistent with the
public interest as determined under such section.'' 21 U.S.C. Sec.
824(a)(4) (emphasis added). With respect to a practitioner, the Act
requires the consideration of the following factors in making the
public interest determination:
(1) The recommendation of the appropriate State licensing board
or professional disciplinary authority.
(2) The applicant's experience in dispensing* * * controlled
substances.
(3) The applicant's conviction record under Federal or State
laws relating to the manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State, Federal, or local laws
relating to controlled substances.
(5) Such other conduct which may threaten the public health and
safety.
Id. Sec. 823(f).
[T]hese factors are * * * considered in the disjunctive.'' Robert
A. Leslie, M.D., 68 FR 15227, 15230 (2003). It is well settled that I
``may rely on any one or a combination of factors, and may give each
factor the weight [I] deem[] appropriate in determining whether a
registration should be revoked.'' Id.; Hoxie v. DEA, 419 F.3d 477, 482
(6th Cir. 2005). Moreover, I am ``not required to make findings as to
all of the factors.'' See Hoxie, 419 F.3d at 482; see also Morall v.
DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005).59
As explained below, I adhere to my initial findings regarding
factors one through four. As found in the original Order, the State of
Florida took no action against Respondent's state medical license and
Respondent has not been convicted of an offense under either Federal or
State laws relating to controlled substances. 71 FR at 52158-59. DEA
has long held, however, that a State's failure to take action against a
registrant's medical license is not dispositive in determining whether
the continuation of a registration is in the public interest. See,
e.g., Mortimer B. Levin, 55 FR 8209, 8210 (1990) (holding that
practitioner's reinstatement by state board ``is not dispositive'';
``DEA maintains a separate oversight responsibility with respect to the
handling of controlled substances and has a statutory obligation to
make its independent determination as to whether the granting of [a
registration] would be in the public interest''). Nor is the fact that
a registrant/applicant has not been convicted of a controlled substance
offense dispositive of whether the continuation of her registration is
in the public interest. See also Edmund Chein, 72 FR 6580, 6593 n.22
(2007).
Pursuant to the Court of Appeals' judgment, I have re-considered
the additional evidence pertaining to Respondent's ``positive
experience.'' Having done so, I again conclude that Respondent violated
Federal law and regulations in issuing the prescriptions to the
undercover operatives. I also conclude that Respondent violated Federal
law and regulations when she pre-signed prescriptions (which she gave
to her nurse) and delegated to him her authority to prescribe
controlled substances, even though he was not registered to prescribe
under Federal law and could not lawfully prescribe controlled
substances under state law. I therefore conclude that Respondent
committed acts inconsistent with the public interest and which support
the suspension or revocation of her registration. 21 U.S.C. 824(a)(4).
However, Respondent has now credibly acknowledged that her
prescribing to the undercover operatives and her pre-signing of the
prescriptions was improper. She has also credibly stated that she has
not engaged in such conduct since the events at issue here and has
promised that she will not do so in the future.\4\ I therefore further
conclude that Respondent has accepted responsibility for her misconduct
and can be entrusted with a new registration subject to the condition
agreed to by the parties.
---------------------------------------------------------------------------
\4\ In the original Order, I acknowledged that Respondent had
undertaken substantial measures to reform her practice. 71 FR at
52156 & 52159.
---------------------------------------------------------------------------
Factor Two and Four--Respondent's Experience in Dispensing Controlled
Substances and Record of Compliance With Applicable Controlled
Substance Laws
Under a longstanding DEA regulation, a prescription for a
controlled substance is not ``effective'' unless it is ``issued for a
legitimate medical purpose by an individual practitioner acting in the
usual course of his professional practice.'' 21 CFR 1306.04(a). Under
the CSA, it is fundamental that a practitioner must establish a
bonafide doctor-patient relationship in order to act ``in the usual
course of * * * professional practice'' and to issue a prescription for
a ``legitimate medical
[[Page 462]]
purpose.'' See United States v. Moore, 423 U.S. 122 (1975); see also 21
CFR 1306.04(a) (``an order purporting to be a prescription issued not
in the usual course of professional treatment * * * is not a
prescription within the meaning and intent of [21 U.S.C. 829] and * * *
the person issuing it, shall be subject to the penalties provided for
violations of the provisions of law related to controlled
substances'').
As the Supreme Court recently explained, ``the prescription
requirement* * * ensures patients use controlled substances under the
supervision of a doctor so as to prevent addiction and recreational
abuse. As a corollary, [it] also bars doctors from peddling to patients
who crave the drugs for those prohibited uses.'' Gonzales v. Oregon,
546 U.S. 243, 274 (2006) (citing Moore, 423 U.S. 122, 135 & 143
(1975)).
In this matter, the Government's presentation largely focused on
two allegations: (1) That Respondent lacked a legitimate purpose in
issuing the prescriptions to the undercover operatives, and (2) that
Respondent pre-signed blank prescriptions which she gave to her nurse
and allowed him to prescribe drugs even though the nurse was not
authorized under either Federal or State law to prescribe controlled
substances.
Whether this conduct is evaluated under factor two--the experience
factor, or factor four--the compliance factor, or both, is of no legal
consequence. In establishing its prima facie case, the fundamental
question is whether Respondent ``has committed such acts as would
render [her] registration * * * inconsistent with the public
interest.'' 21 U.S.C. 824(a)(4). As explained above, this Agency has
long held--and other courts of appeals have at least implicitly
recognized--that findings under a single factor are sufficient to
support the revocation of a registration. See Hoxie, 419 F.3d at 482;
Morall, 412 F.3d at 173-74.
In short, this is not a contest in which score is kept; the Agency
is not required to mechanically count up the factors and determine how
many favor the Government and how many favor the registrant. Rather, it
is an inquiry which focuses on protecting the public interest; what
matters is the seriousness of the registrant's misconduct.\5\
---------------------------------------------------------------------------
\5\ The Court of Appeals interpreted my prior decision as
``[b]alancing the factors and according `dispositive' weight to
factor five.'' Slip. Op. at 5. This suggests that the factors that
favored Respondent's continued registration (factors one and three)
were in equipoise with the factors that did not support her
continued registration. They were not. As explained above, even if
Respondent's conduct had been discussed under a single factor, the
conduct still would have established a prima facie case that her
continued registration was inconsistent with the public interest.
Factor five was dispositive because once the Government established
a prima facie case, the burden shifted to the Respondent to
demonstrate that her continued registration was consistent with the
public interest.
---------------------------------------------------------------------------
As previously found, on three separate occasions, undercover
operatives went to Respondent seeking prescriptions for controlled
substances. Each of the operatives stated that they were not in pain
and that they had been obtaining controlled substances from such non-
legitimate sources as a ``girlfriend'' (first visitor), ``a friend''
(second visitor) and ``a family member who has a prescription'' (third
visitor). 71 FR at 52150, 52152, and 52154. Respondent did not perform
a physical examination on any of the three operatives, even though she
acknowledged that performing a physical exam ``is the standard of
practice'' and ``our Rule No.1.'' Id. at 52154. Moreover, she falsified
each operative's medical record to indicate that she had performed a
physical exam. Id. at 52150 (first visitor), 52153 (second visitor), &
52154 (third visitor).
Most significantly, Respondent's statements as recorded on the wire
amply demonstrate that she knew that the operatives were seeking the
drugs not for the purpose of treating a legitimate medical condition,
but to abuse them. See 71 FR at 52150 (stating to first visitor: ``this
is a shame * * * that you have to take the medicine for the habit,''
``you can tell me that you want to come out of drugs''); id. at 52152
(asking second visitor: ``you don't have pain but you are taking
vicodin?'' and do you ``want to go to substance abuse program or do you
want to be maintained on the vicodin?''); id. (stating to second
visitor: ``maybe I'm sympathetic to the people that allow themselves to
slip into drugs''); id. at 52154 (during visit of third operative, when
asked by her nurse, ``what's the source of the pain?'', replying: ``I
guess he feels no pain, he just feels better.''); id. (stating to third
visitor: ``we will not be supporting just a drug habit'').
In various briefs, Respondent maintains that at the time of the
search, she had already discharged 6 of the 12 patients ``for various
reasons including non-compliance with the Prescription Pain Medication
Agreement, criminal acts or arrest.'' Resp. Exceptions to ALJ Dec. at
42. She contends that this is exculpatory evidence of her intent to not
improperly prescribe drugs. Id.
As found above, it is true that five of the patients whose files
were seized had been discharged before the search was conducted. Yet
even assuming that this evidence is relevant as to Respondent's intent
with respect to her prescribings to the undercover operatives, it is
not more probative of her intent during the visits than the evidence as
to what actually occurred during those visits. Indeed, even if the
operatives' initial statements to Respondent were ambiguous as to why
they were seeking the drugs, Respondent did not perform a physical exam
on any of the operatives (yet falsified the records to indicate that
she had done so) and her subsequent statements during the visits made
clear that she had resolved any doubt as to why the operatives were
seeking the drugs. In short, the evidence is clear that Respondent
issued prescriptions to each of the undercover operatives knowing that
they were seeking controlled substances for the purpose of abusing them
and not to treat a legitimate medical condition.\6\ I thus conclude
that Respondent lacked a legitimate medical purpose and thus violated
Federal law and DEA regulations when she issued the prescriptions to
the undercover operatives.
---------------------------------------------------------------------------
\6\ I acknowledge that some courts allow a defendant in criminal
matters to admit evidence of her ``prior good acts'' to prove she
lacked criminal intent. See United States v. Thomas, 134 F.3d 975,
979 (9th Cir. 1998); United States v. Garvin, 565 F.2d 519, 521-22
(8th Cir. 1977). Putting aside that this is not a criminal
proceeding and the Federal Rules of Evidence do not apply,
Respondent made no showing that the factual circumstances
surrounding her discharging of these patients were similar to the
circumstances involved in the undercover visits. Indeed, in four of
the five instances, the patients had been caught by others engaging
in problematic behavior such as criminal acts present altering or
photocopying prescriptions, (K.L. and J.B.), that the patient was
receiving drugs from another clinic (J.L.), or a report from the
patient's mother that he was abusing drugs (R.S.). RX 21, at 4, 23,
24 and 34.
---------------------------------------------------------------------------
In her exceptions, Respondent argued that ``her treatment of each
of the [twelve] patients [whose files were seized] was proper,'' and
that the ``Government presented no evidence suggesting that the
treatment of those twelve patients was anything but proper.'' Id.
Respondent also contends that she ``properly treated thousands of
patients for chronic pain,'' and that ``the Government was unable to
present any evidence that there was any problem with any non-undercover
patient.'' Id. at 64. Relatedly, the Court of Appeals has instructed
that the experience factor be reconsidered ``pay[ing] particular
attention to the entire corpus of Petitioner's record in dispensing
controlled substances.'' Slip Op. at 3.
As stated above, for the purpose of resolving this matter, I have
assumed that Respondent's prescribings of
[[Page 463]]
controlled substances to every other person she has treated constitute
``positive experience.'' Her prescribings to thousands of other
patients do not, however, render her prescribings to the undercover
officers any less unlawful, or any less acts which ``are inconsistent
with the public interest.'' 21 U.S.C. Sec. 823(f).
In enacting the CSA, Congress recognized that ``[m]any of the drugs
included within [the CSA] have a useful and legitimate medical purpose
and are necessary to maintain the health and general welfare of the
American people.'' 21 U.S.C. 801(1). Moreover, under the CSA, a
practitioner is not entitled to a registration unless she ``is
authorized to dispense * * * controlled substances under the laws of
the State in which [she] practices.'' 21 U.S.C. 823(f). Because under
law, registration is limited to those who have authority to dispense
controlled substances in the course of professional practice, and
patients with legitimate medical conditions routinely seek treatment
from licensed medical professionals, every registrant can undoubtedly
point to an extensive body of legitimate prescribing over the course of
her professional career.
Thus, in past cases, this Agency has given no more than nominal
weight to a practitioner's evidence that he has dispensed controlled
substances to thousands of patients in circumstances which did not
involve diversion. See, e.g., Caragine, 63 FR at 51599 (``[T]he
Government does not dispute that during Respondent's 20 years in
practice he has seen over 15,000 patients. At issue in this proceeding
is Respondent's controlled substance prescribing to 18 patients.'');
id. at 51600 (``[E]ven though the patients at issue are only a small
portion of Respondent's patient population, his prescribing of
controlled substances to these individuals raises serious concerns
regarding [his] ability to responsibly handle controlled substances in
the future.'').
While in Caragine, my predecessor did consider ``that the patients
at issue ma[de] up a very small percentage of Respondent's total
patient population,'' he also noted--in contrast to the prescribings at
issue here--``that [those] patients had legitimate medical problems
that warranted some form of treatment.'' Id. at 51601. Moreover, in
contrast to this case, in Caragine, there was no evidence that the
practitioner had intentionally diverted. Id. See also Medicine Shoppe--
Jonesborough, 73 FR 364, 386 & n.56 (2008) (noting that pharmacy ``had
17,000 patients,'' but that ``[n]o amount of legitimate dispensings can
render * * * flagrant violations [acts which are] `consistent with the
public interest.' ''), aff'd, Medicine Shoppe-Jonesborough v. DEA,
slip. op. at 11 (6th Cir. Nov. 13, 2008). Indeed, DEA has revoked other
practitioners' registrations for committing as few as two acts of
diversion. See Alan H. Olefsky, 57 FR 928, 928-29 (1992) (revoking
registration based on physician's presentation of two fraudulent
prescriptions to pharmacy and noting that the respondent ``refuses to
accept responsibility for his actions and does not even acknowledge the
criminality of his behavior''). See also Sokoloff v. Saxbe, 501 F.2d
571, 576 (2d Cir. 1974) (upholding revocation of practitioner's
registration based on nolo contendere plea to three counts of unlawful
distribution).
Accordingly, evidence that a practitioner has treated thousands of
patients does not negate a prima facie showing that the practitioner
has committed acts inconsistent with the public interest. While such
evidence may be of some weight in assessing whether a practitioner has
credibly shown that she has reformed her practices, where a
practitioner commits intentional acts of diversion and insists she did
nothing wrong, such evidence is entitled to no weight. As I held in the
original decision, I again conclude that Respondent's dispensings to
the undercover officers and her pre-signing of prescriptions and
unlawful delegation of her prescribing authority to her nurse,
establish a prima facie case that her continued registration is
``inconsistent with the public interest.''
Under longstanding Agency precedent, where, as here, ``the
Government has proved that a registrant has committed acts inconsistent
with the public interest, a registrant must `present sufficient
mitigating evidence to assure the Administrator that [he] can be
entrusted with the responsibility carried by such a registration.' ''
Medicine Shoppe, 73 FR at 387 (quoting Samuel S. Jackson, 72 FR 23848,
23853 (2007) (quoting Leo R. Miller, 53 FR 21931, 21932 (1988))).
``Moreover, because `past performance is the best predictor of future
performance,' ALRA Labs, Inc. v. DEA, 54 F.3d 450, 452 (7th Cir. 1995),
[DEA] has repeatedly held that where a registrant has committed acts
inconsistent with the public interest, the registrant must accept
responsibility for [her] actions and demonstrate that [she] will not
engage in future misconduct.'' Medicine Shoppe, 73 FR at 387; see also
Jackson, 72 FR at 23853; John H. Kennedy, 71 FR 35705, 35709 (2006);
Prince George Daniels, 60 FR 62884, 62887 (1995). See also Hoxie v.
DEA, 419 F.3d at 483 (``admitting fault'' is ``properly consider[ed]''
by DEA to be an ``important factor[]'' in the public interest
determination).
In this matter, I previously revoked Respondent's registration
because notwithstanding all of the measures she had undertaken to
reform her practice, she was the person with the prescribing authority
and had refused to acknowledge her responsibility under the law. 71 FR
at 52159. Had this case come back to me with the same evidentiary
record as before, I would again revoke her registration. Respondent,
however, has now acknowledged wrongdoing with respect to both her
prescribings to the undercover operatives, as well as her pre-signing
of prescriptions and delegation of her prescribing authority to her
nurse, who could not legally prescribe a controlled substance under
either the CSA or Florida Law. Moreover, Respondent's registration was
effectively suspended for a period of approximately one year. I
therefore conclude that the parties' proposed resolution of this matter
is in the public interest.
* * * * *
The diversion of controlled substances has become an increasingly
grave threat to this nation's public health and safety. According to
The National Center on Addiction and Substance Abuse (CASA), ``[t]he
number of people who admit abusing controlled prescription drugs
increased from 7.8 million in 1992 to 15.1 million in 2003.'' National
Center on Addiction and Substance Abuse, Under the Counter: The
Diversion and Abuse of Controlled Prescription Drugs in the U.S. 3
(2005). Moreover, ``[a]pproximately six percent of the U.S. population
(15.1 million people) admitted abusing controlled prescription drugs in
2003, 23 percent more than the combined number abusing cocaine (5.9
million), hallucinogens (4.0 million), inhalants (2.1 million) and
heroin (328,000).'' Id. Relatedly, ``[b]etween 1992 and 2003, there has
been a * * * 140.5 percent increase in the self-reported abuse of
prescription opioids,'' and in the same period, the ``abuse of
controlled prescription drugs has been growing at a rate twice that of
marijuana abuse, five times greater than cocaine abuse and 60 times
greater than heroin abuse.'' Id. at 4.\7\
---------------------------------------------------------------------------
\7\ According to a recent newspaper article, ``[p]rescription
painkiller and anti-anxiety drugs now kill about 500 people a year
in the Tampa Bay area, triple the number killed by illegal drugs
such as cocaine and heroin.'' Chris Tisch & Abbie Vansickle, Deadly
Combinations, St. Petersburg Times (Feb. 17, 2008), at 1. This
article further noted that while at the time of publication, the
figures for the year 2007 were not complete, ``the area is on pace
for about 550 deaths,'' and that ``prescription drug overdoses are
likely to overtake car crashes as the leading cause of accidental
death.'' Id. In contrast, in 2006, 433 people died of prescription
drug overdoses, and in 2005, 339 died. Id. According to the Circuit
Judge who runs the Pinellas County drug court, ``This has become an
epidemic.'' Id.
---------------------------------------------------------------------------
[[Page 464]]
While some isolated decisions of this Agency may suggest that a
practitioner who committed only a few acts of diversion was entitled to
regain his registration even without having to accept responsibility
for his misconduct, see Anant N. Mauskar, 63 FR 13687, 13689 (1998),
the great weight of the Agency's decisions are to the contrary. In any
event, the increase in the abuse of prescription controlled substances
calls for a clarification of this Agency's policy. Because of the grave
and increasing harm to public health and safety caused by the diversion
of prescription controlled substances, even where the Agency's proof
establishes that a practitioner has committed only a few acts of
diversion, this Agency will not grant or continue the practitioner's
registration unless he accepts responsibility for his misconduct.\8\
Put another way, even where the Government proves only a few instances
of illegal prescribing in the ``entire corpus'' of a practitioner's
experience, the Government has nonetheless made out a prima facie case
and thus shifted the burden to the registrant to show why he should be
entrusted with a new registration.\9\
---------------------------------------------------------------------------
\8\ Depending upon the facts and circumstances, a registrant/
applicant may also be required to show what corrective measures he/
she has instituted to prevent such acts from re-occurring.
\9\ To the extent Mauskar, or any other decision of this Agency
suggests otherwise, it is overruled.
---------------------------------------------------------------------------
I have abided by the judgment of the Court of Appeals in this
matter. However, some may interpret the Court's decision as suggesting
that ``the entire corpus'' of a practitioner's record in dispensing
controlled substances can outweigh a practitioner's intentional acts of
diversion where DEA only proves that a few acts of diversion have
occurred.
The Court's decision was not published and the Court did not
instruct the Agency as to how much weight the entire corpus should be
given. Nor did the Court explain whether ``the entire corpus'' should
be considered as part of the Government's prima facie case, or as part
of the registrant's rebuttal of the Government's case.
DEA therefore does not interpret the decision as altering the
manner in which similar arguments have been dealt with in prior cases.
While such evidence may have some probative value, it does not negate a
prima facie showing that a registrant/applicant has committed acts that
are inconsistent with the public interest. It may, however, be entitled
to some weight in assessing whether a registrant/applicant has
demonstrated that she can be entrusted with a new registration where
the Government's proof is limited to relatively few acts and a
registrant puts forward credible evidence that she has accepted
responsibility for her misconduct.
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f) &
824(a), as well as 28 CFR 0.100(b) & 0.104, I hereby order that the DEA
Certificate of Registration issued to Jayam Krishna-Iyer, M.D., be, and
it hereby is, suspended. I further order that the suspension shall be
retroactive and limited to the period beginning on October 2, 2006, and
ending on October 2, 2007, when her registration was restored pursuant
to the judgment of the Court of Appeals. I further order that the
application of Jayam Krishna-Iyer, M.D., for renewal of her
registration be, and it hereby is, granted subject to the condition
that she file monthly reports with the Special Agent in Charge (or his
designee) of the Miami Field Division for a period of one year. The
reports shall list all controlled substances prescribed by the
patient's name, the date, the name of the drug, its strength, the
quantity prescribed, and the number of refills authorized. The reports
shall be due no later than the tenth day of the subsequent month and
shall list all patients in alphabetical order.\10\ Failure to comply
with the terms of this Order shall be grounds for the suspension or
revocation of Respondent's registration. This Order is effective
immediately.
---------------------------------------------------------------------------
\10\ If a patient received multiple prescriptions, all
prescriptions issued to the patient within the calendar month shall
be listed before the prescriptions for the next patient are
reported.
Dated: December 19, 2008.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E8-31412 Filed 1-5-09; 8:45 am]
BILLING CODE 4410-09-P
Browse by Year
/ 2009
/ January
/ Tuesday, January 06, 2009
|
|